Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ EBITDA Margin
EBITDA as a percentage of revenue.
Ambiq Micro, Inc.NYSE: AMBQ
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to -33.6%
EBITDA Margin was -33.6% in Q1 FY2026, up 6.5 pp from a year earlier. On a trailing-twelve-month basis it was -38.3%, up 3.3 pp year over year.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 5 analysts of 3.1% for the fiscal year ending Dec 2026, up from -40.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -33.6%+9.8 pp QoQ
- Last fiscal yearDec 2025
- -40.3%+3.6 pp YoY
- LTMMar 2026
- -38.3%+3.3 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +6.5 pp | +23.7 pp | +17.2 pp |
| 1 year | +3.6 pp | +43.4 pp | +39.8 pp |
| 3 years | — | +46.3 pp | — |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -40.3%
- Year-over-year change
- +3.6pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -40.3% | +3.6pp |
| FY2024 | 2024-12-31 | -43.9% | +21.1pp |
| FY2023 | 2023-12-31 | -65.0% | — |
| FY2021 | 2021-12-31 | -24.0% | +11.9pp |
| FY2020 | 2020-12-31 | -35.9% | — |
EBITDA Margin vs competitors
How AMBQ compares with its peers on the latest reported figures
- AMBQ's LTM Mar 2026 EBITDA Margin of -38.3% is the 6th highest of the 10 companies compared; the peer median is -7.9%.
- Its year-over-year change of +3.3 pp is the 7th highest of 10, against a peer median of +14.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 24.3% | +39.3 pp | -34.0 pp | |
| LTM Mar 2026 | 12.5% | +152.4 pp | +53.7 pp | |
| LTM Mar 2026 | 4.2% | +14.8 pp | +34.3 pp | |
| LTM Mar 2026 | -3.0% | +1.4 pp | +17.7 pp | |
| LTM Apr 2026 | -7.9% | +12.1 pp | +17.8 pp | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | -38.3% | +3.3 pp | — |
| LTM Mar 2026 | -41.9% | -3.4 pp | +8.2 pp | |
| LTM Mar 2026 | -168.3% | -91.3 pp | -120.4 pp | |
| LTM Mar 2026 | -218.1% | +2742.1 pp | +1001.2 pp | |
| LTM Mar 2026 | -5522.1% | +15675.6 pp | -1973.0 pp | |
NBPNovaBridge Biosciences | FY2025 | — | — | — |
| Peer median (excluding AMBQ) | -7.9% | +14.8 pp | +17.7 pp | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 50.97M | 91.01M | 65.54M | 76.07M | 72.51M |
| Cost of Revenue | 29.4M | 60.24M | 46.1M | 51.78M | 46.82M |
| Gross Profit | 21.57M | 30.77M | 19.44M | 24.29M | 25.7M |
| Gross Margin | 42.3% | 33.8% | 29.7% | 31.9% | 35.4% |
| Research & Development | 27.79M | 36.11M | 44.02M | 37.17M | 33.69M |
| Selling, General & Admin | 14M | 19.13M | 26.74M | 27.74M | 33.15M |
| Operating Expenses | 41.79M | 55.87M | 70.76M | 64.9M | 66.84M |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| EBITDA | (18.29M) | (21.85M) | (42.59M) | (33.39M) | (29.21M) |
| EBITDA Margin | -35.9% | -24.0% | -65.0% | -43.9% | -40.3% |
| Operating Income | (20.22M) | (25.1M) | (51.32M) | (40.61M) | (41.14M) |
| Operating Margin | -39.7% | -27.6% | -78.3% | -53.4% | -56.7% |
| Interest Income | 0 | 43K | 0 | 0 | 0 |
| Interest Expense | 4.58M | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (4.98M) | (216K) | 1.02M | 980K | 4.72M |
| Income Before Tax | (25.2M) | (25.32M) | (50.3M) | (39.63M) | (36.42M) |
| Pre-Tax Margin | -49.4% | -27.8% | -76.8% | -52.1% | -50.2% |
| Income Tax Expense | 25K | 25K | 30K | 28K | 40K |
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Net Margin | -49.5% | -27.8% | -76.8% | -52.1% | -50.3% |
| EPS (Basic) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| EPS (Diluted) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| Weighted Avg Shares | 13.61M | 248.89M | 10.45M | 13.54M | 7.98M |
| Weighted Avg Shares (Diluted) | 13.61M | 248.89M | 10.45M | 13.61M | 7.98M |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.